Abbonarsi

Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness - 14/04/20

Doi : 10.1016/j.jaad.2019.10.079 
Nour Kibbi, MD, Yuemei Zhang, MD, MBA, David J. Leffell, MD, Sean R. Christensen, MD, PhD
 Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 

Correspondence to: Sean R. Christensen, MD, PhD, Yale Dermatologic Surgery, 40 Temple Street, Suite 5A, New Haven, CT 06510.Yale Dermatologic Surgery40 Temple Street, Suite 5ANew HavenCT06510

Abstract

Background

Photodynamic therapy (PDT) has been reported as a treatment for cutaneous squamous cell carcinoma in situ (SCCis), but only limited data are available on the effectiveness of PDT with aminolevulinic acid (ALA-PDT).

Objective

To review the outcomes of SCCis treated with ALA-PDT and examine factors associated with response.

Methods

A retrospective review identified 58 patients with 68 primary SCCis lesions treated with ALA-PDT and blue light illumination. Patient demographics, lesion features, treatment details, clinical response, and subsequent recurrence were extracted from medical record reviews.

Results

On completion of PDT the initial complete response rate was 77.9% and was not associated with the number of PDT treatments. On multivariate analysis factors associated with response were location on the face, tumor diameter <2 cm, and longer ALA incubation time. Lesions treated with a maximum incubation time of <3 hours had a 53.3% response compared with 84.9% for longer incubation. Subsequent recurrence of SCCis was noted in 7 of 53 cases (13.2%) at a median time of 11.7 months.

Limitations

This was a retrospective study performed at a single institution without systematic follow-up.

Conclusions

ALA-PDT may be an effective treatment for selected cases of SCCis. Effectiveness is impacted by anatomic location, tumor diameter, and ALA incubation time.

Il testo completo di questo articolo è disponibile in PDF.

Key words : aminolevulinic acid, Bowen disease, humans, photodynamic therapy, retrospective studies, skin neoplasms, squamous cell carcinoma in situ, treatment outcome

Abbreviations used : ALA, ALA-PDT, CR, PDT, SCCis


Mappa


 Funding sources: Supported by a Career Development Award from the Dermatology Foundation (Dr Christensen).
 Conflicts of interest: None disclosed.
 IRB approval status: Reviewed and approved by the Yale Institutional Review Board (IRB number 2000024076).
 Reprints not available from the authors.


© 2019  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 82 - N° 5

P. 1124-1130 - maggio 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center
  • Alexandra M. Bender, Olive Tang, Raveena Khanna, Sonja Ständer, Sewon Kang, Shawn G. Kwatra
| Articolo seguente Articolo seguente
  • Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: A nationwide population-based study
  • Ying-Xiu Dai, Ying-Hsuan Tai, Chih-Chiang Chen, Yun-Ting Chang, Tzeng-Ji Chen, Mu-Hong Chen

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.